Table 4.
Demographic, clinical, and laboratory characteristics according to HDL-C levels in male versus female population.
| Parameters | Males | Females | ||||
|---|---|---|---|---|---|---|
| Low HDL (N = 71) |
Normal HDL (N = 213) |
P value | Low HDL (N = 5) |
Normal HDL (N = 65) |
P value | |
| Mean ± SD/N (%) | Mean ± SD/N (%) | Significance | Mean ± SD/N (%) | Mean ± SD/N (%) | Significance | |
| Age (years) | 53.98 ± 14.48 | 50.29 ± 12.60 | 0.047 | 64.80 ± 4.43 | 58.33 ± 12.70 | 0.05 |
| Left ventricular dysfunction | ||||||
| Absent | 13 (18.3) | 39 (18.3) | 0.85 | 1 (20) | 23 (35.4) | 0.02 |
| Mild | 24 (33.8) | 64 (30) | 0.65 | 1 (20) | 20 (30.8) | 1.00 |
| Moderate | 19 (26.8) | 57 (26.8) | 0.87 | 2 (40) | 10 (15.4) | 0.42 |
| Severe | 15 (21.1) | 53 (24.9) | 0.63 | 1 (20) | 12 (18.5) | 0.60 |
| Diagnosis | ||||||
| CSA | 11 (15.5) | 35 (16.4) | 1.00 | 1 (20) | 13 (20) | 0.56 |
| ACS | 60 (84.5) | 178 (83.6) | 4 (80) | 52 (80) | ||
| Outcome | ||||||
| Discharge | 65 (91.5) | 203 (95.3) | 0.37 | 5 (100) | 60 (92.3) | 0.79 |
| Expired | 6 (8.5) | 10 (4.7) | 0 | 5 (7.7) | ||
| Hemoglobin (gm/dL) | 13.27 ± 2.14 | 12.98 ± 1.99 | 0.48 | 8.98 ± 4.50 | 11.09 ± 1.79 | <0.01 |
| WBC (per cmm) | 12.55 ± 6.90 | 11.64 ± 4.20 | 0.01 | 9.46 ± 6.03 | 10.41 ± 4.01 | 0.37 |
| Neutrophil (%) | 74.78 ± 12.7 | 73.97 ± 11.31 | 0.26 | 70.8 ± 13.47 | 69.41 ± 12.28 | 0.63 |
| Lymphocyte (%) | 19.80 ± 11.38 | 20.87 ± 15.98 | 0.99 | 23.80 ± 2.73 | 24.63 ± 11.53 | 0.59 |
| Platelets (per cmm) | 2.74 ± 1.00 | 2.83 ± 1.09 | 0.318 | 2.02 ± 0.73 | 2.96 ± 0.89 | 0.80 |
| Monocyte (%) | 2.92 ± 1.37 | 3.08 ± 1.36 | 0.303 | 3.0 ± 1.0 | 3.12 ± 1.25 | 0.43 |
| Eosinophils (%) | 2.52 ± 1.52 | 2.61 ± 1.25 | 0.711 | 2.40 ± 0.54 | 2.83 ± 1.65 | 0.53 |
| NLR | 5.96 ± 5.10 | 5.17 ± 3.82 | 0.030 | 4.53 ± 3.66 | 3.97 ± 2.81 | 0.21 |
| PLR | 206.06 ± 188.4 | 184.90 ± 136.2 | 0.024 | 138.29 ± 128.1 | 154.42 ± 103.9 | 0.30 |
| TC (gm/dL) | 171.08 ± 49.90 | 153.22 ± 47.62 | 0.587 | 147.80 ± 24.62 | 158.96 ± 42.52 | 0.21 |
| Triglycerides (mg/dL) | 109.40 ± 58.45 | 138.47 ± 78.20 | 0.065 | 119.19 ± 56.07 | 136.46 ± 70.58 | 0.95 |
| LDL (mg/dL) | 102.67 ± 43.42 | 95.73 ± 39.02 | 0.125 | 67.45 ± 17.94 | 96.45 ± 34.06 | 0.10 |
| VLDL (mg/dL) | 21.88 ± 11.69 | 27.74 ± 15.64 | 0.062 | 23.83 ± 11.21 | 27.30 ± 14.12 | 0.95 |
| LDL/HDL | 2.22 ± 0.92 | 3.38 ± 1.85 | 0.059 | 1.20 ± 0.35 | 2.90 ± 1.39 | 0.11 |
| TC/HDL | 3.70 ± 1.04 | 5.36 ± 2.37 | 0.028 | 2.64 ± 0.56 | 4.74 ± 1.79 | 0.18 |
| Total lipids (mg/dL) | 626.97 ± 96.26 | 649.95 ± 427.0 | 0.340 | 623.51 ± 72.10 | 630.68 ± 12.76 | 0.75 |
CSA: chronic stable angina, ACS: acute coronary syndrome, WBC: white blood cell, NLR: neutrophil-lymphocyte ratio, PLR: platelet-lymphocyte ratio, TC: total cholesterol, HDL: high density lipoprotein, LDL: low density lipoprotein, and VLDL: very low density lipoprotein. Level of significance was accepted at P < 0.05.